Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre

Similar documents
Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. Poland: HCV Patients Association Prometeusze

Primary and secondary hepatitis prevention and control programmes The Netherlands

HepC Break Through project

Lucca March 13th-14th Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe.

Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Lucca, Italy March 2008

VHPB MEETING ANTWERP 2014 ACHIEVEMENTS AND CHALLENGES IN PREVENTION AND CONTROL OF VIRAL HEPATITIS

Paolo Deluca, PhD Psychologist, Cooperativa di Studio e Ricerca Sociale Marcella

Seasonal Influenza Programme The Netherlands. Joost Timmermans Coordinator National Programme Influenza Protection

New WHO global injection safety initiative

The birthof the Dutch National hepatitis plan

National Hepatitis plan. Dr JP Mulkay Clinic of Hepatology Department of Hepato Gastro entrology

RD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS

CURING HEPATITIS C IN GENERAL PRACTICE: THE FIRST 60 DAYS

Integrating Hepatitis Services into HIV Programs: Working Together to Meet Community Needs

Health Care Workers and Viral Hepatitis in Turkey. Bulent Degertekin M.D. Viral Hepatitis Prevention Board Meeting

Understanding vaccine hesitancy in a post-factual era

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany

The Haemophilia Society s submission to NICE for the appraisal of hepatitis C (mild to moderate) pegylated interferons, ribavirin and alpha interferon

2. What type of general services does your organization provide? Please check all that apply.

Toronto Declaration: Strategies to control and eliminate viral hepatitis globally. A call for coordinated action

Paul Zantkuijl, beleidsmedewerker MSM Soa Aids Nederland

Hepatitis B: A Preventable Cause of Liver Cancer. Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016

Leading Australia towards the elimination of viral hepatitis

Zambia infection prevention guidelines & application in health care facilities

Certification of Haemophilia Treatment Centres in Europe: The EHC View

2016 NYC Hep B Coalition Work Plan

Hepatitis C Strategy. About us. What is hepatitis C?

ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD

Appendix 11 Roles and Responsibilities October, 2013 Page 1 of 5

TANZANIA NATIONAL STRATEGIC PLAN FOR CONTROL OF VIRAL HEPATITIS

Beyond vaccine introduction: Working together for sustainable, resilient immunization programs Manufacturer perspective

Integration of Hepatitis B and Hepatitis C into the National Occupational Diseases List

Blood and Body Fluid Exposure

Hepatitis prevention in the context of HIV prevention point work in Latvia

Eliminating Viral Hepatitis in Australia: Where are we in 2017?

School Nursing and Health. Standard Precautions. (aka Universal Precautions)

Provincial Infectious Diseases Advisory Committee Public Health Response to Hepatitis C

Toronto Declaration 2014: Global Strategies to control and eliminate viral hepatitis globally. A call for coordinated action

healthdirect Symptom Checker Communications Toolkit

World Hepatitis Alliance Strategic Plan 2015

Engaging to Improve Access Zack Pemberton-Whiteley. Head of Campaigns and Advocacy Leukaemia CARE, UK

HIV, HBV and HCV testing policy experiences and lessons learned.

Need for Chronic Viral Hepatitis Monitoring System

Viral Hepatitis. WHO Regional Office for Europe July 2013

Prevention and control of hepatitis B and C in the European Region of WHO

Navigating vaccine introduction: a guide for decision-makers JAPANESE ENCEPHALITIS (JE) Module 4. How should my country introduce JE vaccines?

standards for vaccinators and guidelines for organisations offering immunisation services

A handbook for people who have injected drugs

Global strategy on viral hepatitis and regional action plan: monitoring framework and 10 core indicators

Health care associated viral hepatitis in the Netherlands

Integrating hepatitis C treatment in a regional setting The Cairns Experience. DANA 2018 Morag Goodinson

European HIV-Hepatitis Testing Week

Effective Date: 6/10/2013 Review Date: 6/10/2016

keyword: hepatitis Hepatitis

Global Patient Survey. Country-Specific Report China

Global Patient Survey. Country-Specific Report Belgium

Translating from bench- to bedside: vitamin D in multiple sclerosis

QuADS Organisational Standards and Professional Competencies in needle exchange

WHAT IS HEPATITIS C? 2 DOES HEPATITIS C AFFECT PREGNANCY? HOW DO I GET TREATED FOR HEPATITIS C?

LUNG CANCER FINDING YOUR BEST CARE

Healthy Workplaces for All Ages Promoting a sustainable working life

Tailoring Seasonal Influenza Immunization Programmes for Health Care Workers

INFECTION PREVENTION AND CONTROL POLICY AND PROCEDURES Sussex Partnership NHS Foundation Trust (The Trust)

Alcohol Research UK Research Strategy

Resourced civil society organisations should work hand-in-hand with the government to move to the grassroots.

The Imp.Ac.T.project. Improving Access to HIV/TB Testing for marginalized groups

From the Chief Medical Officer Dr Michael McBride

7th International Symposium on Hepatitis Care in Substance Users

The new WHO global injection safety policy and campaign

HIV/AIDS Control in the Republic of Korea

in cooperation with the World Health Organization Hanoi, Vietnam

HEALTH SERVICES POLICY & PROCEDURE MANUAL

5 th Islamic Conference of Health Ministers. Resolution. Istanbul, Turkey November 2015 (5-7 Safar 1437H)

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

Healthy Pathways Forward Progress Report. May

Modelling and Simulation in Public Health

Primary Care Services for blood borne viral hepatitis prevention, treatment and care

Risk Consultation and Assessment

Nursing and Midwifery students only. Section 1: Information

Setting the Stage Key Challenges in Elimination

The Role of Liver Societies in the Global Viral Hepatitis Response

STRATEGIC PLAN

Country Disease Area Patient Advocacy Group Name Description of the Contracted Services (when applicable)

IOF TOOLKIT IOF COMPENDIUM OF OSTEOPOROSIS. Our vision is a world without fragility fractures, in which healthy mobility is a reality for all.

IMPORTANT THINGS TO KNOW WHEN YOU HAVE HEPATITIS C

Vertical integration of health and social care for older people living with frailty in the Netherlands

Mid Essex Specialist Dementia and Frailty Service

Hepatitis B and C Summit Conference Brussels, 14th-15th October, 2010 REPORT

PHILLY HEPATITIS ANSWERS ABOUT HEPATITIS

Item 4. Sexual Health and Blood Borne Virus Strategy Strategy for Sexual Health and Blood Borne Viruses. Background

Tajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan

HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report

Emma Zurowski PaSH Programme Lead BHA for Equality. Peter Bampton Sexual Health Lead LGBT Foundation. gmpash.org.uk.

Network Meeting for Prison and Health. Kyiv, Ukraine 14 November December Summary report

How are Blood borne pathogens harmful? How do you come into contact with Blood-borne pathogens?

The next steps

HCV Elimination in Egypt

Bradford District Community Advice Network (CAN)

Rostros de la gripe:* Ethnic and Minority Community Influenza Vaccination Outreach Targeting Hispanics

PH52. Audit tool for the implementation of. NICE public health guidance 52 Needle and syringe programmes

Transcription:

Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre

1) History of the organisation(s) Founded in 1997 by: Dutch liver patient association Haemophilia patient association supported by liver specialists Lack of information for patients Low awareness by healthcare workers

Objectives and role of the NHC Improving the coordination and cooperation of activities on hepatitis; Documenting and disseminating the knowledge, expertise and experience; Advancing education and information on (the prevention of) hepatitis; Supporting patients with hepatitis; Offering expertise to healthcare workers and others; Offering facilities to associations, organisations and foundations that have similar objectives; Identifying gaps in knowledge and expertise regarding hepatitis

Organisation of the NHC NHC is a knowledge and information centre It is a foundation We don t have members NHC Board Representatives of patient organisations, hepatologists and a independent chairman NHC Advisory Committee Scientifics from different area's: Medical care, occupational healthcare, public health, addiction care Office 3 staff workers (1 fulltime, 2 part-time) 3 project leaders

4) Target audience General public Brochures Website Helpline Patients and patient organisations Lobby and advocacy to government and policy makers Education and support for patient self support groups Individual support for patients (under antiviral treatment) Professionals / healthcare workers Guidelines Education and training Website

NHC structural activities Information and advice website, brochures, helpline, digital newsletter Training and education Health professionals GP s, nurses, public health care workers Occupational healthcare professionals (company doctors etc) Always evidence based national and international guidelines and expert opinions

NHC project activities National hepatitis week ( education) National Hepatitis C campaign ( awareness) Symposia for policymakers ( lobbying) Project Short Chain ( project HBV ) Project centres for blood exposure accident Project hepatitis B and pregnancy (coordination) Project case study on safety systems to prevent needle stick accidents

6) Services and Activities: Prevention Lobby for hepatitis B vaccination for all newborns Lobby for free vaccination programs for (patient) groups at risk Vaccination against hepatitis A and B for patient with chronic liver disease ( successful completed) Vaccination for all the people with a mental handicap ( still working on this) Vaccination for occupational risk groups ( some successes, still working on that) NHC support to prevention of occupational exposure Needle stick accidents guidelines Education and training program Study on the introduction of safety systems in healthcare

7) Support and Financing Structural activities are financial supported by: Ministry of health since 2007 delegated to the Centre of Infectious Disease prevention (CIb) Pharmaceutical company s Projects are financial supported by: Different national funds governmental others (funds from insurance company s) Pharmaceutical company s

8) Other related groups active in your country Patient organisations Patients self-support groups National Institute for disease prevention governmental partner in the hepatitis C campaign Mainline Support for patients with drugs related hepatitis Partner in the hepatitis C campaign

9 Strengths NHC is working from a patient perspective NHC is independent NHC works evidence based NHC is accessible for everyone NHC is a meeting place for medical, social, public health and politic working fields on hepatitis

10A) Challenges Arase awareness on hepatitis General public is interested in HIV and bird flew but not in hepatitis A lot of hepatitis patients don t speak Dutch Convincing the government and politics that hepatitis is a sever health issue Netherlands is a low endemic country It is a health problem from elsewhere Motivating public health and first line healthcare to: active detection of hepatitis Develop detection programs for ethnic groups (cultural tailoring) Work together in access to treatment ( chain of disease management)

10B) Challenges and thresholds toward support of improved prevention National vaccination program hepatitis B!!! To see detection and treatment of hepatitis patients as Prevention of severe liver disease and Second prevention in spreading the disease

11) Conclusions The Netherlands is a low endemic country 0,4 % HBV and 0,15-0,4 % HCV We mustn t make the National problem bigger than is is But that is also the pitfall More hepatitis patients through immigration Less attention of politic and government Less experience by general practitioners and other healthcare workers competition with other healthcare problems It is our duty to see to it that all hepatitis patients gets the right to information and access to testing and treatment